Immunovant Ownership | Who Owns Immunovant?


OverviewForecastRevenueFinancialsChart

Immunovant Ownership Summary


Immunovant is owned by 53.69% institutional investors, 55.64% insiders. Fmr is the largest institutional shareholder, holding 8.94% of IMVT shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.04% of its assets in Immunovant shares.

IMVT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockImmunovant53.69%55.64%-9.34%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr13.10M8.94%$324.44M
Vanguard group6.68M4.56%$165.45M
Deep track capital, lp6.00M4.10%$148.62M
Blackrock4.92M3.56%$129.79M
Blackrock funding, inc. /de5.14M3.51%$127.39M
Armistice capital3.40M2.46%$89.68M
State street2.72M1.97%$71.78M
Viking global investors lp2.32M1.68%$61.27M
Alpine global management1.91M1.38%$50.36M
Woodline partners lp1.82M1.32%$48.14M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Alpine global management1.91M8.76%$50.36M
Deep track capital, lp6.00M5.54%$148.62M
Adar1 capital management787.48K3.90%$19.51M
Tyro capital management250.62K3.00%$6.62M
Two seas capital lp692.41K2.97%$18.28M
Prosight management, lp325.00K2.56%$8.58M
Paradigm biocapital advisors lp1.36M1.38%$35.98M
Logos global management lp575.00K1.22%$15.18M
Redmile group720.18K1.15%$19.01M
Boxer capital825.00K1.15%$21.78M

Top Buyers

HolderShares% AssetsChange
Deep track capital, lp6.00M5.54%1.65M
T. rowe price investment management1.63M0.03%1.63M
Armistice capital3.40M1.13%1.23M
Jpmorgan chase1.15M0.00%925.08K
Norges bank637.95K0.00%637.95K

Top Sellers

HolderShares% AssetsChange
Point72 asset management---1.38M
Logos global management lp575.00K1.22%-1.20M
Capital research global investors---976.24K
State street2.72M0.00%-922.95K
Commodore capital lp---750.99K

New Positions

HolderShares% AssetsChangeValue
T. rowe price investment management1.63M0.03%1.63M$42.91M
Norges bank637.95K0.00%637.95K$15.80M
Bnp paribas arbitrage, snc85.20K0.00%85.20K$2.11M
Mirae asset global etfs32.96K0.00%32.96K$867.92K
Knights of columbus asset advisors24.87K0.04%24.87K$616.10K

Sold Out

HolderChange
Reuter james wealth management-1.00
Capital performance advisors llp-3.00
Nelson, van denburg & campbell wealth management group-11.00
Cibc private wealth group-17.00
Innealta capital-59.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024204-4.23%78,645,3575.27%532.05%94-14.55%64-
Jun 30, 2024211-10.21%74,707,0257.20%542.33%1090.93%63-23.17%
Mar 31, 2024235-7.11%69,688,1951.94%482.16%108-20.00%823.80%
Dec 31, 202325318.22%68,360,1722.16%471.80%1351.50%7971.74%
Sep 30, 202321436.31%66,916,90020.66%512.53%13349.44%464.55%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O4.45M3.04%196.00K
Fidelity Growth Compy Commingled Pl S4.93M2.91%135.89K
Fidelity Growth Company Fund3.48M2.05%-11.50K
T. Rowe Price Small-Cap Stock2.09M1.43%207.91K
T. Rowe Price US Small-Cap Core Equity2.09M1.43%806.13K
Vanguard Total Stock Mkt Idx Inv2.08M1.42%3.50K
Vanguard Small Cap Index1.68M1.15%17.95K
iShares Russell 2000 ETF1.58M0.93%-12.05K
Vanguard Small Cap Value Index Inv1.12M0.76%-4.84K
T. Rowe Price Instl Small-Cap Stock1.11M0.76%172.65K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 22, 2025Stout Jay S Chief Technology OfficerSell$51.78K
Jan 22, 2025Geffner Michael Chief Medical OfficerSell$62.68K
Jan 15, 2025Macias William L. Chief Medical OfficerSell$9.21K
Jan 15, 2025Macias William L. Chief Medical OfficerSell$2.27K
Jan 15, 2025Macias William L. Chief Medical OfficerSell$44.83K

Insider Transactions Trends


DateBuySell
2025 Q1112
2024 Q4-16
2024 Q3-28
2024 Q2-23
2024 Q1-14

IMVT Ownership FAQ


Who Owns Immunovant?

Immunovant shareholders are primarily institutional investors at 53.69%, followed by 55.64% insiders and -9.33% retail investors. The average institutional ownership in Immunovant's industry, Biotech Stocks , is 109.70%, which Immunovant falls below.

Who owns the most shares of Immunovant?

Immunovant’s largest shareholders are Fmr (13.1M shares, 8.94%), Vanguard group (6.68M shares, 4.56%), and Deep track capital, lp (6M shares, 4.10%). Together, they hold 17.60% of Immunovant’s total shares outstanding.

Does Blackrock own Immunovant?

Yes, BlackRock owns 3.56% of Immunovant, totaling 4.92M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 129.79M$. In the last quarter, BlackRock increased its holdings by 439.33K shares, a 9.81% change.

Who is Immunovant’s biggest shareholder by percentage of total assets invested?

Alpine global management is Immunovant’s biggest shareholder by percentage of total assets invested, with 8.76% of its assets in 1.91M Immunovant shares, valued at 50.36M$.

Who is the top mutual fund holder of Immunovant shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Immunovant shares, with 3.04% of its total shares outstanding invested in 4.45M Immunovant shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools